Millipore Sigma Vibrant Logo

376817 Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem

The Hexokinase II Inhibitor II, 3-BP, also referenced under CAS 1113-59-3, controls the biological activity of Hexokinase II. This small molecule/inhibitor is primarily used for Cell Structure applications.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid

View Products on Sigmaaldrich.com
376817
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
1113-59-3C₃H₃BrO₃

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
376817-100MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 100 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA cell-permeable pyruvic acid derivative that acts as an inhibitor against hexokinase II-mediated glycolysis and effectively suppress tumor survival both in cultures in vitro and in mice and rats in vivo.
      Catalogue Number376817
      Brand Family Calbiochem®
      Synonyms3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid
      References
      ReferencesBujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.
      Product Information
      CAS number1113-59-3
      EC number214-206-5
      FormWhite crystalline solid
      Hill FormulaC₃H₃BrO₃
      Chemical formulaC₃H₃BrO₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by Titration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSUZ0840000
      Safety Information
      R PhraseR: 34

      Causes burns.
      S PhraseS: 26-36/37/39-45

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Corrosive
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      376817-100MG 04055977212983

      Documentation

      Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Hexokinase II Inhibitor II, 3-BP - CAS 1113-59-3 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      376817

      Referencias bibliográficas

      Visión general referencias
      Bujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-December-2010 RFH
      Synonyms3-BrPA, Bromopyruvate, Bromopyruvatic Acid, 3-Bromo-2-oxopropionic acid
      DescriptionA cell-permeable pyruvic acid derivative that acts as an inhibitor against hexokinase II-mediated glycolysis and effectively suppress tumor survival both in cultures in vitro and in mice and rats in vivo.
      FormWhite crystalline solid
      CAS number1113-59-3
      RTECSUZ0840000
      EC number214-206-5
      Chemical formulaC₃H₃BrO₃
      Structure formulaStructure formula
      Purity≥97% by Titration
      SolubilityDMSO (100 mg/ml) or dH₂O (100 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Corrosive
      ReferencesBujis, M., et al. 2009. Invest. New Drugs 27, 120.
      Chen, Z., et al. 2009. Biochim. Biophys. Acta. 1787, 553.
      Hulleman, E., et al. 2009. Blood. 113, 2014;
      Mathupala, S.P., et al. 2009. Semin. Cancer Biol. 19, 17.
      Pereira da Silva, A.P., et al. 2009. Biochem. J. 417, 717.
      Yun, J., et al. 2009. Science. 325, 1555.
      Zhang, X., et al. 2009. Anticancer Res. 29, 1443.
      Kim, J.S., et al. 2008. J. Bioenerg. Biomembr. 40, 607.